Table 4 Calcimimetics and oral VDRA (vitamin D receptor activator) use, 2019
From: Annual dialysis data report 2019, JSDT Renal Data Registry
Calcimimetics use | None | Alfacalcidol | Calcitriol | Erdecalcitol | Farecalcitriol | Others | Subtotal | Unspecified | No information available | Total |
|---|---|---|---|---|---|---|---|---|---|---|
None | 118,016 | 51,961 | 12,190 | 1,050 | 1,577 | 297 | 185,091 | 269 | 1293 | 1,86,653 |
(%) | (63.8) | (28.1) | (6.6) | (0.6) | (0.9) | (0.2) | (100.0) | |||
Cinacalcet | 8,841 | 3,468 | 887 | 43 | 190 | 22 | 13,451 | 24 | 429 | 13,904 |
(%) | (65.7) | (25.8) | (6.6) | (0.3) | (1.4) | (0.2) | (100.0) | |||
Etercalcetide | 23,891 | 4,143 | 1,424 | 185 | 226 | 22 | 29,891 | 37 | 1214 | 31,142 |
(%) | (79.9) | (13.9) | (4.8) | (0.6) | (0.8) | (0.1) | (100.0) | |||
Evocalcet | 25,308 | 9,137 | 2,850 | 304 | 616 | 47 | 38,262 | 62 | 1302 | 39,626 |
(%) | (66.1) | (23.9) | (7.4) | (0.8) | (1.6) | (0.1) | (100.0) | 2,71,325 | ||
Subtotal | 176,056 | 68,709 | 17,351 | 1,582 | 2,609 | 388 | 266,695 | 392 | 4238 | |
(%) | (66.0) | (25.8) | (6.5) | (0.6) | (1.0) | (0.1) | (100.0) | |||
Unspecified | 245 | 40 | 3 | Â | 1 | Â | 289 | 761 | 5 | 1055 |
(%) | (84.8) | (13.8) | (1.0) | Â | (0.3) | Â | (100.0) | |||
No information available | 420 | 2,179 | 437 | 21 | 57 | 18 | 3,132 | 29 | 57,058 | 60,219 |
(%) | (13.4) | (69.6) | (14.0) | (0.7) | (1.8) | (0.6) | (100.0) | |||
Total | 1,76,721 | 70,928 | 17,791 | 1,603 | 2,667 | 406 | 2,70,116 | 1,182 | 61,301 | 332,599 |
(%) | (65.4) | (26.3) | (6.6) | (0.6) | (1.0) | (0.2) | (100.0) |